Cargando…

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer

BACKGROUND: Variation in tumor biology in African-American (AA) and Caucasian (CAU) women with breast cancer is poorly defined. Activated leukocyte cell adhesion molecule (ALCAM) is a bad prognostic factor of breast cancer yet it has never being studied in the AA population. We tested the hypothesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Fang, Mosunjac, Marina, Adams, Amy L, Adade, Beverly, Taye, Oleyad, Hu, Yijuan, Rizzo, Monica, Ofori-Acquah, Solomon F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190464/ https://www.ncbi.nlm.nih.gov/pubmed/25255861 http://dx.doi.org/10.1186/1471-2407-14-715

Ejemplares similares

ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
por: Tachezy, Michael, et al.
Publicado: (2012)

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2015)

ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles
por: Cardeñes, Beatriz, et al.
Publicado: (2022)

ANGI-03 Functional roles of CD166/activated leukocyte cell adhesion molecule (CD166/ALCAM) for glioblastoma invasion
por: Kijima, Noriyuki, et al.
Publicado: (2020)

Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells
por: Tan, Fang, et al.
Publicado: (2010)

CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells
por: Fujiwara, Kenji, et al.
Publicado: (2014)

Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis
por: Hooker, R.A., et al.
Publicado: (2015)

ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation
por: Brinkhof, Bas, et al.
Publicado: (2020)

The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
por: Yang, Yiming, et al.
Publicado: (2021)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

Cell Adhesion Molecule CD166/ALCAM Functions Within the Crypt to Orchestrate Murine Intestinal Stem Cell Homeostasis
por: Smith, Nicholas R., et al.
Publicado: (2017)

Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases
por: Ihnen, M., et al.
Publicado: (2010)

A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
por: Wiiger, Merete Thune, et al.
Publicado: (2010)

Global Gene Expression Profiling of Endothelium Exposed to Heme Reveals an Organ-Specific Induction of Cytoprotective Enzymes in Sickle Cell Disease
por: Ghosh, Samit, et al.
Publicado: (2011)

ALCAM-EGFR interaction regulates myelomagenesis
por: Luo, Hongmei, et al.
Publicado: (2021)

Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer
por: Jeong, Young Ju, et al.
Publicado: (2018)

ALCAM Makes It All Calm by Inhibiting Apoptosis
por: Chen, Peter, et al.
Publicado: (2022)

Different Subcellular Localization of ALCAM Molecules in Neuroblastoma: Association with Relapse
por: Corrias, Maria Valeria, et al.
Publicado: (2010)

ALCAM regulates multiple myeloma chemoresistant side population
por: Wang, Fangfang, et al.
Publicado: (2022)

The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
por: Chalmers, Samantha A., et al.
Publicado: (2022)

Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer’s disease
por: Chen, Jian, et al.
Publicado: (2023)

Bertillón 166
por: Soler Puig, José, 1916-
Publicado: (1960)

Bertillón 166
por: Soler Puig, José
Publicado: (1960)

Bertillón 166
por: Soler Puig, José, 1916-
Publicado: (1987)

The SickleGenAfrica Network
por: Ofori-Acquah, Solomon F
Publicado: (2020)

Oboensonate Opus 166 = Oboe sonata op. 166
por: Saint-Saëns, Camille, 1835-1921
Publicado: (2010)

ALCAM(+) stromal cells: role in giant cell tumor of bone progression
por: Zhou, Zhenhua, et al.
Publicado: (2018)

Optimization and Characterization of Novel ALCAM-Targeting Antibody Fragments for Transepithelial Delivery
por: Bauer, Aline, et al.
Publicado: (2023)

ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions
por: Willrodt, Ann-Helen, et al.
Publicado: (2019)

ALCAM: A Novel Surface Marker on EpCAM(low) Circulating Tumor Cells
por: Signorelli, Rossana, et al.
Publicado: (2022)

NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop
por: Wang, Jiayi, et al.
Publicado: (2011)

Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand
Publicado: (1995)

IAU Colloquium No. 166
por: Breitschwerdt, Dieter, et al.
Publicado: (1998)

Memorandum: experiment S166
por: Brückner, W
Publicado: (1981)

S166. Submission Withdrawn
Publicado: (2018)

ALCAM Regulates Motility, Invasiveness, and Adherens Junction Formation in Uveal Melanoma Cells
por: Jannie, Karry M., et al.
Publicado: (2012)

Depending on Its Nano-Spacing, ALCAM Promotes Cell Attachment and Axon Growth
por: Thelen, Karsten, et al.
Publicado: (2012)

Expression and Role of CD166 in the Chronic Kidney Disease
por: Sun, Yan, et al.
Publicado: (2015)

Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation
por: Rambaldi, Benedetta, et al.
Publicado: (2022)

Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction
por: Cho, WonKyung J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hnqqeejtr4ftvj05oq5vi7gc2h